Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
1-Alkyl-2-acetylglycerophosphocholine Esterase < 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine < 1-Methyl-4-phenylpyridinium  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 63.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000081 (1999) E. Grünblatt [Israël] ; S. Mandel ; T. Berkuzki ; M B YoudimApomorphine protects against MPTP-induced neurotoxicity in mice.
000117 (1999) B. Henry [Royaume-Uni] ; S H Fox ; D. Peggs ; A R Crossman ; J M BrotchieThe alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease.
000268 (2000) D A Di Monte [États-Unis] ; A. Mccormack ; G. Petzinger ; A M Janson ; M. Quik ; W J LangstonRelationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
000279 (2000) I. Ghorayeb [France] ; P O Fernagut ; I. Aubert ; E. Bezard ; Werner Poewe [Autriche] ; G K Wenning ; F. TisonToward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
000329 (2000) S A Treseder [Royaume-Uni] ; L A Smith ; P. JennerEndogenous dopaminergic tone and dopamine agonist action.
000458 (2001) H. Turmel [France] ; A. Hartmann ; K. Parain ; A. Douhou ; A. Srinivasan ; Yves Agid [France] ; E C HirschCaspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
000461 (2001) G M Petzinger [États-Unis] ; M. Quik ; E. Ivashina ; M W Jakowec ; M. Jakubiak ; D. Di Monte ; J W LangstonReliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate.
000538 (2001) E C Maratos [Royaume-Uni] ; M J Jackson ; R K Pearce ; P. JennerAntiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naïve MPTP-lesioned common marmosets (Callithrix jacchus).
000539 (2001) S H Fox [Royaume-Uni] ; B. Henry ; M P Hill ; D. Peggs ; A R Crossman ; J M BrotchieNeural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan.
000580 (2001) R E Yee [États-Unis] ; I. Irwin ; C. Milonas ; D B Stout ; S C Huang ; K. Shoghi-Jadid ; N. Satyamurthy ; L E Delanney ; D M Togasaki ; K F Farahani ; K. Delfani ; A M Janson ; M E Phelps ; J W Langston ; J R BarrioNovel observations with FDOPA-PET imaging after early nigrostriatal damage.
000647 (2002) Maria C. Obinu [France] ; Michel Reibaud ; Véronique Blanchard ; Saliha Moussaoui ; Assunta ImperatoNeuroprotective effect of riluzole in a primate model of Parkinson's disease: behavioral and histological evidence.
000886 (2002) Ronald K B. Pearce [Royaume-Uni] ; Lance A. Smith ; Michael J. Jackson ; Tara Banerji ; Jorgen Scheel-Krüger ; Peter JennerThe monoamine reuptake blocker brasofensine reverses akinesia without dyskinesia in MPTP-treated and levodopa-primed common marmosets.
000887 (2002) Lance A. Smith [Royaume-Uni] ; Banu C. Tel ; Michael J. Jackson ; Matthew J. Hansard ; Rogelio Braceras ; Céline Bonhomme ; Claire Chezaubernard ; Susanna Del Signore ; Sarah Rose ; Peter JennerRepeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation.
000888 (2002) Louis C. Tan [États-Unis] ; Peter H. Protell ; J William Langston ; Daniel M. TogasakiThe hyperkinetic abnormal movements scale: a tool for measuring levodopa-induced abnormal movements in squirrel monkeys.
000927 (2002) Susan H. Fox [Royaume-Uni] ; Brian Henry ; Michael Hill ; Alan Crossman ; Jonathan BrotchieStimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
000946 (2002) Mikko Kuoppam Ki [Royaume-Uni] ; Ghassan Al-Barghouthy ; Michael Jackson ; Lance Smith ; Bai-Yun Zeng ; Niall Quinn ; Peter JennerBeginning-of-dose and rebound worsening in MPTP-treated common marmosets treated with levodopa.
000975 (2003) Jay S. Schneider [États-Unis] ; Timothy V. WadeExperimental parkinsonism is associated with increased pallidal GAD gene expression and is reversed by site-directed antisense gene therapy.
000991 (2003) Peter Teismann [États-Unis] ; Kim Tieu ; Oren Cohen ; Dong-Kug Choi ; Du Chu Wu ; Daniel Marks ; Miquel Vila ; Vernice Jackson-Lewis ; Serge PrzedborskiPathogenic role of glial cells in Parkinson's disease.
000A52 (2003) Lance A. Smith [Royaume-Uni] ; Michael J. Jackson ; Matthew J. Hansard ; Eleni Maratos ; Peter JennerEffect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure.
000A92 (2003) Michael Orth [Royaume-Uni] ; Sarah J. TabriziModels of Parkinson's disease.
000B35 (1992) B. Gomez-Mancilla [Canada] ; R. Boucher ; P J BédardEffect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024